Aurinia Pharmaceuticals Inc. (AUPH) vs SELLAS Life Sciences Group, Inc. (SLS)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and SELLAS Life Sciences Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aurinia Pharmaceuticals Inc. logo
AUPH
Aurinia Pharmaceuticals Inc.
$2.01B
$15.60HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SELLAS Life Sciences Group, Inc. logo
SLS
SELLAS Life Sciences Group, Inc.
$2.11B
$11.36HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — AUPH vs SLS

growth of $100 · dividends reinvested · last 10y
AUPH +288.1% (+14.5%/yr)SLS -99.9% (-49.4%/yr)AUPH compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$388$0
AUPH SLS

AUPH vs SLS: by the numbers

  • •SLS is the larger company ($2.11B vs $2.01B market cap).
  • •AUPH is profitable (100.84% net margin) while SLS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAUPHSLS
P/E ratio6.81N/A
Forward P/E16.53N/A
P/S ratio6.44N/A
P/B ratio3.2615.35
EV / EBITDA11.09N/A
FCF yield8.65%N/A

Profitability

MetricAUPHSLS
Gross margin90.36%0.00%
Operating margin37.06%0.00%
Net margin100.84%0.00%
ROE51.09%-23.58%
ROIC21.77%-25.45%

Growth (annualized)

MetricAUPHSLS
Revenue CAGR (5Y)40.17%N/A
Total return CAGR (5Y)-5.88%6.20%

Frequently asked

Is AUPH or SLS more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus SLS at 0.00%.
How have AUPH and SLS total returns compared?
Over the past 10 years, AUPH delivered 14.53% and SLS delivered -49.07% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AUPH analysisFull SLS analysisInteractive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratioAurinia Pharmaceuticals ROESELLAS Life Sciences ROEAurinia Pharmaceuticals operating marginSELLAS Life Sciences operating marginAurinia Pharmaceuticals revenue growthSELLAS Life Sciences revenue growthAurinia Pharmaceuticals free cash flowSELLAS Life Sciences free cash flow

Aurinia Pharmaceuticals & SELLAS Life Sciences appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.